XM does not provide services to residents of the United States of America.

Top potash producer Nutrien to stop blending fertilizer in Brazil, sources say



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Top potash producer Nutrien to stop blending fertilizer in Brazil, sources say</title></head><body>

By Ana Mano

SAO PAULO, July 19 (Reuters) -Nutrien NTR.TO, the world's largest potash producer, will stop blending fertilizers in Brazil after deciding to shut its last two active processing plants in the country, said three people familiar with the latest phase of a major turnaround effort.

The sources, who requested anonymity as the move has not been announced, said the plan to halt blending operations at Nutrien's Itapetininga and Araxa units is another step to reposition the company on the local market.

The Canadian firm declined to comment.

Nutrien is shifting its focus to reselling farm inputs through its network of local retailers in Brazil as part of a sharp strategic shift after acquisitions and investments failed to yield the expected returns.

In May 2022, when Nutrien was still investing to boost fertilizer blending capacity in Brazil, the company said it planned to have a total of 12 such facilities in the country.

Two years on, Nutrien indefinitely halted three of its five Brazilian blenders as part of the ongoing reorganization. Two of the sources said Nutrien has also closed several Brazil retail locations this year due to tough market conditions.

The company declined to comment on its dwindling retail network in Brazil, a major importer of fertilizers.

Nutrien has been working on a turnaround in the region since April 2023, when senior executives started leaving the company amid reorganization.

Last year, Nutrien booked a $465 million impairment charge related to its South American acquisitions. In March, Reuters first reported Nutrien decided to sell assets in the region.

As Nutrien shrinks to improve results, the departure of another three director-level Brazilian employees was announced this week in an internal memo seen by Reuters.

Nutrien declined to comment on the departures.



Reporting by Ana Mano; Editing by Brad Haynes and Arun Koyyur

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.